BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15636138)

  • 1. [Characterization of antirubella vaccine in an epidemiological trial].
    Popov VF; Iunasova TN; Gaĭderova LA; Aksenov LA; Averina OB; Shitikova OIu
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):41-3. PubMed ID: 15636138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rubella in Russia: the detection of congenital rubella and the vaccination strategy and procedures].
    Semerikov VV; Popov VF; Sedel'nikova TA; Iunasova TN; Kaplunova OP; Kolotov ME; Nikolova IV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):46-9. PubMed ID: 9532685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
    Okafuji T; Okafuji T; Nakayama T
    Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella virus immunization of preschool children via the respiratory tract.
    Ganguly R; Durrer B; Waldman RH
    Am J Dis Child; 1974 Dec; 128(6):821-3. PubMed ID: 4440651
    [No Abstract]   [Full Text] [Related]  

  • 6. Rubella reimmunization now.
    Balfour HH
    Am J Dis Child; 1979 Dec; 133(12):1231-3. PubMed ID: 517469
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of immunization against rubella.
    Mountifield J
    Prim Care; 1978 Dec; 5(4):717-23. PubMed ID: 253369
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
    Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
    Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 11. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
    Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 14. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
    Samoĭlovich EO; Kapustik LA; Fel'dman EV; Ermolovich MA; Svirchevskaia EIu; Titov LP; Zakharenko DF; Belova EIu; Chernovetskiĭ MA; Korostik TS
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):36-40. PubMed ID: 9783398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children.
    Vesikari T; Ala-Laurila EL; Heikkinen A; Terho A; D'Hondt E; André FE
    Am J Dis Child; 1984 Sep; 138(9):843-7. PubMed ID: 6383020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.